Dr. Falk Pharma Benelux BV (Q4016680): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in es: Adding Spanish translations)
(‎Removed claims)
Property / instance of
 
Property / instance of: Kohesio project / rank
Normal rank
 
Property / financed by
 
Property / financed by: European Union / rank
Normal rank
 
Property / country
 
Property / country: Netherlands / rank
Normal rank
 
Property / co-financing rate
50.0 percent
Amount50.0 percent
Unitpercent
 
Property / co-financing rate: 50.0 percent / rank
Normal rank
 
Property / start time
19 February 2016
Timestamp+2016-02-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / start time: 19 February 2016 / rank
Normal rank
 
Property / end time
19 February 2017
Timestamp+2017-02-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / end time: 19 February 2017 / rank
Normal rank
 
Property / beneficiary name (string)
Dr. Falk Pharma Benelux BV
 
Property / beneficiary name (string): Dr. Falk Pharma Benelux BV / rank
Normal rank
 
Property / beneficiary
 
Property / beneficiary: Q4009937 / rank
Normal rank
 
Property / intervention field
 
Property / intervention field: Active and healthy ageing / rank
Normal rank
 
Property / postal code
4818CP
 
Property / postal code: 4818CP / rank
Normal rank
 
Property / fund
 
Property / fund: European Social Fund / rank
Normal rank
 
Property / programme
 
Property / programme: Netherlands - ESF / rank
Normal rank
 

Revision as of 20:31, 17 January 2022

Project Q4016680 in Netherlands
Language Label Description Also known as
English
Dr. Falk Pharma Benelux BV
Project Q4016680 in Netherlands

    Statements

    Identifiers

    2015EUSF201637
    0 references